BioLife Solutions, Inc. - Common Stock — Bilancio Trimestrale (NASDAQ:BLFS) | MetaTrader

Apri il grafico completo Full chart

Notizie

Casdin Capital ed Eli Casdin vendono azioni NASDAQ:BLFS per $28,1 mln

BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates

Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates

ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway

4 Medical Product Stocks to Buy From a Challenging Industry

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

Wall Street Analysts Think BioLife Solutions (BLFS) Could Surge 70.78%: Read This Before Placing a Bet

After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)

BioLife Looks Strong For Fiscal Year 2026 (NASDAQ:BLFS)

Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade

BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript